Organization
University of Rochester
47 clinical trials
12 abstracts
Abstract
SWOG S1826, a randomized study of nivolumab(N)-AVD versus brentuximab vedotin(BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL).Org: City of Hope National Medical Center, Emory University School of Medicine, Weill Cornell Medicine, Research Institute of McGill University Health Centre, Princess Margaret - University Health Network,
Abstract
Incidence round screening performance among women with dense breasts undergoing abbreviated breast MRI and digital breast tomosynthesis (ECOG-ACRIN EA1141).Org: Brown University School of Public Health, Brown University School of Medicine-Rhode Island Hospital, University of Washington School of Medicine, Memorial Sloan Kettering Cancer Center, University of Rochester,
Abstract
Effect of a telephone-based weight loss intervention (WLI) on weight at 12-months in women with early breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.Org: Weill Cornell Medicine, Mount Sinai Hospital-Breast Medical Oncology, Massachusetts General Hospital, UM/Sylvester Comprehensive Cancer Center, UNC Patient Advocates for Research Council,
Abstract
Payor denial after prior authorization request for long-acting pain medication: Provider and patient perspectives.Org: Memorial Sloan Kettering Cancer Center, University of Rochester, The University of North Carolina at Chapel Hill, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center,
Abstract
Effects of immune-enhancing nutrition on radical cystectomy outcomes: Primary results from the randomized phase III double-blind clinical trial (S1600).Org: University of Kansas Medical Center, Kansas City, KS, SWOG Statistics and Data Management Center, Seattle, WA, Fred Hutchinson Cancer Center, Seattle, WA,
Abstract
Walking dose required to achieve a clinically meaningful reduction in cancer-related fatigue among patients with breast cancer receiving chemotherapy: A URCC NCORP nationwide prospective cohort study.Org: James P. Wilmot Cancer Center, University of Rochester Medical Center, University of Rochester School of Medicine & Dentistry, University of Rochester, Providence Cancer Institute,
Abstract
Primary treatment modification strategies among older adults with advanced cancer.Org: University of Rochester Medical Center, University of Rochester, The University of North Carolina at Chapel Hill, University of Rochester School of Medicine and Dentistry, James P. Wilmot Cancer Center,
Abstract
Disparities in stage at presentation for disaggregated Asian American, Native Hawaiian, and Pacific Islander (AANHPI) groups with breast cancer.Org: University of Pennsylvania, Harvard University, Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, University of Rochester, University of Pittsburgh,
Abstract
Clinicians’ perspectives on the Telehealth Serious Illness Care Program for older adults with myeloid malignancies.Org: University of Rochester School of Medicine & Dentistry, Rochester, NY, University of Rocheser Medical Center, University of Rochester, University of Rochester Medical Center,
Abstract
Reasons for unmet care needs in older adults with cancer: Analyses from the 2015–2019 National Health and Aging Trends Study.Org: University of Rocheser Medical Center, Rochester, NY, University of Rochester School of Medicine and Dentistry, University of Rochester Medical Center, James P. Wilmot Cancer Center,
Abstract
Importance of information-seeking styles among patients with cancer pre- and post-treatment: A URCC NCORP Research Base study.Org: University of Rocheser Medical Center, Rochester, NY, James P. Wilmot Cancer Center, University of Rochester Medical Center, University of Rochester,
Clinical trial
A Comparison of Immunogenicity of Licensed RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) to Community-dwelling Older AdultsStatus: Active (not recruiting), Estimated PCD: 2024-11-01
Abstract
Safety and efficacy of first-in-class CXCR1/2 inhibitor SX-682 in combination with pembrolizumab (pem) in patients (pts) with metastatic melanoma (mMEL) with disease progression on anti–PD-1 therapy.Org: Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Mayo Clinic, Rochester, MN, USA, University of Rochester, Rochester, NY, Massachusetts General Hospital, Marblehead, MA, Dana-Farber Cancer Institute, Boston, MA, USA,
Clinical trial
Topical Ruxolitinib (Jak1/Jak2 Inhibitor) in Chronic Hand Dermatitis Attenuates Inflammation and Enhances Skin Barrier RepairStatus: Active (not recruiting), Estimated PCD: 2023-06-21
Clinical trial
A Phase II Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell LymphomaStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Risperidone for the Treatment of Huntington's Disease ChoreaStatus: Completed, Estimated PCD: 2023-12-30
Clinical trial
A Pilot Study of Cisplatin in Castration Resistant Prostate Cancer That is Becoming Refractory to EnzalutamideStatus: Completed, Estimated PCD: 2023-07-31
Clinical trial
Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer: A Phase II StudyStatus: Active (not recruiting), Estimated PCD: 2022-06-01
Clinical trial
Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease - Randomized, Double-blind, Placebo-controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Exploratory Study of Ruxolitinib Cream for the Treatment of Discoid Lupus ErythematosusStatus: Completed, Estimated PCD: 2024-03-04
Clinical trial
A Feasibility Study of De-escalation of Chemotherapy in Patients With Early-Stage HER2 Positive Breast CancerStatus: , Estimated PCD: 2025-06-01
Clinical trial
A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of CancerStatus: Not yet recruiting, Estimated PCD: 2030-01-01
Clinical trial
The Effects of Disulfiram on Visual Acuity in Patients With Retinal DegenerationStatus: Not yet recruiting, Estimated PCD: 2025-04-15
Clinical trial
An Open-label Phase 1 Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal AdenocarcinomaStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Pilot Study to Determine the Safety and Efficacy of Repeated Hyperbaric Oxygen Therapy in Multiple Myeloma Patients Undergoing High-Dose Therapy and Autologous Stem/Progenitor TransplantationStatus: Recruiting, Estimated PCD: 2024-05-15
Clinical trial
Randomized, Double-Blind Clinical Study Evaluating Efficacy of Intravenous Versus Enteric Acetaminophen in Donor Nephrectomy and Robot-Assisted, Laparoscopic Nephrectomy.Status: Recruiting, Estimated PCD: 2024-07-31
Clinical trial
A Phase I Study to Determine the Preferred Dose of the Angiotensin Converting Enzyme Inhibitor Lisinopril for Preventing Urinary Toxicity Following Radiotherapy for Prostate CancerStatus: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
A Phase II Study of Enzalutamide Plus Dutasteride/Finasteride as First Line Treatment for Vulnerable Patients ≥ 65 Years With Systemic Prostate CancerStatus: Completed, Estimated PCD: 2023-10-31
Clinical trial
Reducing Frailty for Older Cancer Survivors Using Supplements (ReFOCUS): A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of CancerStatus: Completed, Estimated PCD: 2023-08-31
Clinical trial
A Phase 1 Study to Assess Safety and Feasibility of Methylene Blue Photodynamic Therapy to Sterilize Deep Tissue Abscess CavitiesStatus: Completed, Estimated PCD: 2023-09-01
Clinical trial
Safety, Feasibility, and Tolerability of Sulforaphane in Children With CKDStatus: Recruiting, Estimated PCD: 2024-08-31
Clinical trial
An Open-Label Phase II Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 SignalingStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Selinexor for the Treatment of Patients With Intermediate and High-Risk Smoldering Multiple MyelomaStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Aggressive Antipyretics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance EffectsStatus: Completed, Estimated PCD: 2022-12-02
Clinical trial
Denosumab for Smoldering Multiple MyelomaStatus: Active (not recruiting), Estimated PCD: 2022-09-16
Clinical trial
The Effect of High-Dose Vitamin D and Physical Activity on Bone Health in Breast Cancer Patients Receiving Hormonal TherapyStatus: Active (not recruiting), Estimated PCD: 2024-04-30
Clinical trial
Efficacy of Curcumin and Piperine in Patients on Active Surveillance for Either Monoclonal Gammopathy of Unknown Significance (MGUS), Low-risk Smoldering Multiple Myeloma (SMM) or Early Stage Prostate Cancer: A Pilot StudyStatus: Recruiting, Estimated PCD: 2024-05-31
Clinical trial
A Phase II Study of Steroid Sparing Treatment With Daratumumab and Lenalidomide in Newly Diagnosed Transplant Ineligible Patients With Multiple MyelomaStatus: Recruiting, Estimated PCD: 2024-07-31
Clinical trial
The Role of Dopamine in the Central Neural Signature of Chronic PainStatus: Recruiting, Estimated PCD: 2024-12-22
Clinical trial
A Pilot Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2Status: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
Randomized Control Trial Of Mifepristone for FibroidsStatus: Completed, Estimated PCD: 2010-06-01
Clinical trial
A Phase 2 Study to Assess Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue AbscessesStatus: Not yet recruiting, Estimated PCD: 2029-12-01
Clinical trial
Evaluating the Effects of Dietary Supplementation With Remune on Cancer Associated Weight and Muscle Loss With and Without Exercise: A Randomized Pilot Feasibility Study.Status: Completed, Estimated PCD: 2021-01-13
Clinical trial
Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation (DAPA-AF) Prospective, Randomized, Multicenter, Placebo-Controlled TrialStatus: Completed, Estimated PCD: 2023-03-31
Clinical trial
A Phase 1b/2 Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular CarcinomaStatus: Withdrawn, Estimated PCD: 2028-12-31
Clinical trial
Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse GliomasStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Induction Chemotherapy for Locally Advanced Esophageal Cancer: A Phase II StudyStatus: Active (not recruiting), Estimated PCD: 2024-06-12
Clinical trial
Phase II Study of Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated CLL/SLLStatus: Active (not recruiting), Estimated PCD: 2023-05-19
Clinical trial
Study of Testosterone and rHGH in FSHD (STARFISH): A Proof-of-Concept StudyStatus: Completed, Estimated PCD: 2022-03-28
Clinical trial
Phase 2 Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCLStatus: Recruiting, Estimated PCD: 2024-07-31
Clinical trial
A Randomized Phase II Study Evaluating the Efficacy of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
Pilot Study of Neoadjuvant Dual Checkpoint Blockade With Concurrent Radiation in Resectable Soft Tissue SarcomaStatus: Active (not recruiting), Estimated PCD: 2024-08-01
Clinical trial
A Pilot Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)Status: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
Umbilical Cord Blood Transplantation From Unrelated DonorsStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Early Changes in Type 2 Inflammatory Cytokines, Respiratory Oscillometry, and Sinonasal Microbiome With Dupilumab Treatment for Chronic Rhinosinusitis With Nasal PolypsStatus: Withdrawn, Estimated PCD: 2026-06-01
Clinical trial
Near InfraRed Fluorescence Imaging of Lymphatic Transport Using Indocyanine Green: Phase II PilotStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Serologic Response to a New Recombinant, Adjuvanted Herpes Zoster Vaccine in Patients With Chronic Lymphocytic Leukemia and Waldenström Macroglobulinemia Treated With First-Line BTK Inhibitors - A Pilot StudyStatus: Completed, Estimated PCD: 2020-09-01
Clinical trial
Pilot Trial of Ustekinumab for Primary Sjögren's SyndromeStatus: Completed, Estimated PCD: 2022-05-11